Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

KRN-7000-stimulated human cells effective in vitro against melanoma cell lines

Dec. 13, 1999

ImmunoGen's lead tumor-activated prodrug enters the clinic

Dec. 13, 1999

LifeTime receives FDA clearance to begin phase I/II trials of anticancer drug

Dec. 10, 1999

Avax Technologies and Neptunus execute joint venture agreement

Dec. 3, 1999

Schering in-licenses human antibody for gastric cancer

Dec. 2, 1999

Biomira enters collaborative agreement, licenses two patents for cancer vaccine

Nov. 29, 1999

Preliminary survival data from single Maxamine site submitted to ASCO

Nov. 24, 1999

AAPS news: clinical pharmacokinetic analysis of B43-genistein in patients

Nov. 23, 1999

Novel prostate cancer therapy in development at Procyon detailed at international conference

Nov. 23, 1999

NY-ESO-1-derived peptides and their use in cancer therapy and diagnosis

Nov. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...